Chrysin’s ability to inhibit NLRP3 inflammasome activation further highlights its therapeutic potential, particularly in conditions like hepatic fibrosis [179] and synovial inflammation [180]. This evidence concerns the gene NLRP3 and Hepatic fibrosis.